JP2019500876A5 - - Google Patents

Download PDF

Info

Publication number
JP2019500876A5
JP2019500876A5 JP2018535126A JP2018535126A JP2019500876A5 JP 2019500876 A5 JP2019500876 A5 JP 2019500876A5 JP 2018535126 A JP2018535126 A JP 2018535126A JP 2018535126 A JP2018535126 A JP 2018535126A JP 2019500876 A5 JP2019500876 A5 JP 2019500876A5
Authority
JP
Japan
Prior art keywords
culture
glycan
monoclonal antibody
man
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018535126A
Other languages
English (en)
Japanese (ja)
Other versions
JP6674028B2 (ja
JP2019500876A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/012349 external-priority patent/WO2017120347A1/en
Publication of JP2019500876A publication Critical patent/JP2019500876A/ja
Publication of JP2019500876A5 publication Critical patent/JP2019500876A5/ja
Application granted granted Critical
Publication of JP6674028B2 publication Critical patent/JP6674028B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018535126A 2016-01-06 2017-01-05 モノクローナル抗体組成物中のアフコシル化種の調節 Active JP6674028B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662275384P 2016-01-06 2016-01-06
US62/275,384 2016-01-06
PCT/US2017/012349 WO2017120347A1 (en) 2016-01-06 2017-01-05 Modulation of afucosylated species in a monoclonal antibody composition

Publications (3)

Publication Number Publication Date
JP2019500876A JP2019500876A (ja) 2019-01-17
JP2019500876A5 true JP2019500876A5 (enExample) 2020-02-13
JP6674028B2 JP6674028B2 (ja) 2020-04-01

Family

ID=57944513

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018535126A Active JP6674028B2 (ja) 2016-01-06 2017-01-05 モノクローナル抗体組成物中のアフコシル化種の調節

Country Status (8)

Country Link
US (1) US20190161543A1 (enExample)
EP (1) EP3400241B1 (enExample)
JP (1) JP6674028B2 (enExample)
CN (1) CN109153716A (enExample)
AU (1) AU2017206006B2 (enExample)
CA (1) CA3010598A1 (enExample)
MX (1) MX2018008447A (enExample)
WO (1) WO2017120347A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6526025B2 (ja) 2013-10-16 2019-06-05 オンコバイオロジクス,インコーポレイティド 抗体安定性を増強する緩衝液製剤
US10696735B2 (en) 2015-01-21 2020-06-30 Outlook Therapeutics, Inc. Modulation of charge variants in a monoclonal antibody composition
CN109563161A (zh) 2016-02-03 2019-04-02 安口生物公司 用于提高抗体稳定性的缓冲制剂
CN119639849A (zh) * 2018-03-26 2025-03-18 美国安进公司 细胞培养物中产生的抗体的总去岩藻糖基化糖型
HU231514B1 (hu) 2018-11-07 2024-07-28 Richter Gedeon Nyrt. Sejttenyészetben előállított rekombináns glikoprotein glikozilációs mintázatának megváltoztatására szolgáló módszer
SG11202106481SA (en) * 2018-12-19 2021-07-29 Seagen Inc Controlled fucosylation of antibodies
WO2021066772A1 (en) * 2019-10-01 2021-04-08 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Cell culture medium for reducing fucosylation and basic variants in the production of antibodies
KR20230145083A (ko) * 2021-02-12 2023-10-17 론자 벤드 인코포레이티드 항체 생성물의 비푸코실화를 조절하는 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090382A (en) 1996-02-09 2000-07-18 Basf Aktiengesellschaft Human antibodies that bind human TNFα
US8227241B2 (en) 2004-03-12 2012-07-24 Unigene Laboratories, Inc. Bacterial host cell for the direct expression of peptides
ATE515566T1 (de) 2005-05-26 2011-07-15 Cytos Biotechnology Ag Skalierbares fermentationsverfahren
US7846724B2 (en) 2006-04-11 2010-12-07 Hoffmann-La Roche Inc. Method for selecting CHO cell for production of glycosylated antibodies
CN102076865B (zh) * 2008-05-02 2016-03-16 西雅图基因公司 用于制造核心岩藻糖基化降低的抗体和抗体衍生物的方法和组合物
US8409838B2 (en) * 2009-06-02 2013-04-02 Regeneron Pharmaceuticals, Inc. Fucosylation-deficient cells
US20120277165A1 (en) * 2009-06-05 2012-11-01 Collins Brian E Methods of modulating fucosylation of glycoproteins
US20120258496A1 (en) 2010-09-27 2012-10-11 Boehringer Ingelheim International Gmbh Production of low fucose antibodies in h4-ii-e rat cells
WO2013114165A1 (en) * 2012-01-30 2013-08-08 Dr Reddy's Laboratories Limited Process of obtaining glycoprotein composition with increased afucosylation content
NO2760138T3 (enExample) * 2012-10-01 2018-08-04
WO2015140700A1 (en) * 2014-03-19 2015-09-24 Dr. Reddy's Laboratories Limited Cell culture process
WO2017079165A1 (en) * 2015-11-02 2017-05-11 Genentech, Inc. Methods of making fucosylated and afucosylated forms of a protein

Similar Documents

Publication Publication Date Title
Li et al. Serum-free medium for recombinant protein expression in Chinese hamster ovary cells
Carrillo-Cocom et al. Amino acid consumption in naïve and recombinant CHO cell cultures: producers of a monoclonal antibody
JP6982578B2 (ja) 細胞培養培地
RU2642285C1 (ru) Способ получения целевого антитела с модулированным галактозилированием (варианты) и способ модулирования галактозилирования целевого антитела (варианты) путем оптимизации культуральной среды
Masterton et al. The impact of process temperature on mammalian cell lines and the implications for the production of recombinant proteins in CHO cells
RU2008152449A (ru) Получение гликопротеинов
IL201395A (en) Multi-clonal cell lines and methods for generating multi-clonal cell lines
RU2013152982A (ru) Способ снижения гетерогенности антител и способ получения соответствующих антител
UA120048C2 (uk) Антигензв'язуючий фрагмент антитіла, який специфічно зв'язується з рецептором інсуліноподібного фактора росту 1 (igf1r)
JP2016513478A5 (enExample)
JP2022515820A5 (enExample)
MX2018008447A (es) Modulacion de especies afucosilados en una composicion de anticuerpo monoclonal.
IL313983A (en) Fully fucose-free glycoforms of antibodies are produced in cell culture
JP2016523910A5 (enExample)
MX2018008448A (es) Reducción de especies de alto peso molecular, especies con carga ácida, y fragmentos en una composición de anticuerpo monoclonal.
CN104560882A (zh) 一种降低酸性变体含量的cho细胞培养工艺
Amribt et al. Optimization and robustness analysis of hybridoma cell fed-batch cultures using the overflow metabolism model
JP2022540920A (ja) 高密度連続接種の細胞培養方法及びその応用
IL307155B2 (en) Antibodies with modulated glycan profiles
Yoon et al. Biphasic culture strategy for enhancing volumetric erythropoietin productivity of Chinese hamster ovary cells
Lee et al. Effect of hypoosmotic pressure on cell growth and antibody production in recombinant Chinese hamster ovary cell culture
Shi et al. Controlled growth of Chinese hamster ovary cells and high expression of antibody-IL-2 fusion proteins by temperature manipulation
Mahboudi et al. The role of different supplements in expression level of monoclonal antibody against human CD20
Fan et al. Effect of culture temperature on TNFR-Fc productivity in recombinant glutamine synthetase-chinese hamster ovary cells
CN103397034A (zh) miRNA-19a作为哺乳动物宿主细胞增殖调控靶标的应用